Join to view full profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Giridhar is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2015 - 2018
University of California (San Francisco)Residency, Internal Medicine, 2013 - 2015- University of California (San Francisco)Internship, Internal Medicine, 2012 - 2013
University of Pittsburgh School of MedicineClass of 2012
Certifications & Licensure
CA State Medical License 2014 - Present
MN State Medical License 2015 - 2026
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity Patient Online, GE Healthcare, 2016-2017
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2016-2017
- CMS Meaningful Use Stage 1 Certification Mayo Clinic Incorporate Lab Results, Mayo Clinic, 2016-2017
Publications & Presentations
PubMed
- Advancing the Oncology Data Paradigm: Multisite Expansion of Structured Cancer Data Capture at the Point of Care.Christopher D Vetter, Clare Gatten, Pooja Advani, Sara Chumsri, Karthik Giridhar
JCO Oncology Practice. 2026-07-02 - CLO26-104: TBCRC 050: A Phase 1b/2 Trial of Niraparib and Trastuzumab in HER2+ Metastatic Breast Cancer (MBC): Safety and Efficacy.Erica Stringer-Reasor, Yufeng Li, Jianqing Zhang, Gabrielle Rocque, Kyla Jones
Journal of the National Comprehensive Cancer Network. 2026-03-31 - CLO26-104: TBCRC 050: A Phase 1b/2 Trial of Niraparib and Trastuzumab in HER2+ Metastatic Breast Cancer (MBC): Safety and Efficacy.Erica Stringer-Reasor, Yufeng Li, Jianqing Zhang, Gabrielle Rocque, Kyla Jones
Journal of the National Comprehensive Cancer Network. 2026-03-31
Press Mentions
A More Personalized Approach to Breast Cancer CareJanuary 6th, 2025- Debunking Myths About CancerJune 10th, 2022
- Large Study Shows Multi-Cancer Early Detection Test Increases Cancer DetectionJune 2nd, 2026
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
